Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

IGFBP4 Activators

IGFBP4, a protein primarily responsible for the modulation of IGF activities, interacts with an array of cellular pathways. Chemicals known to affect these pathways, by extension, can influence the expression, activity, or interactions of IGFBP4. For instance, the PI3K/Akt pathway, known for its pivotal role in IGF signaling, can be targeted by chemicals such as LY294002, Wortmannin, and ZSTK474. By inhibiting this pathway, there's an indirect modulation of the cellular processes that IGFBP4 is involved in. Similarly, the mTOR pathway, another essential player in IGF signaling, can be affected by Rapamycin, leading to potential changes in IGFBP4's operational landscape.

Furthermore, the MAPK/ERK pathway, influenced by chemicals like PD98059 and U0126, plays a role in various cell functions, including growth and differentiation. By altering this pathway, one can infer an indirect impact on IGFBP4's expression or activity. Another facet is the role of AMPK activators like Metformin and A-769662. AMPK, being an energy sensor, has opposing actions to IGF signaling in certain contexts. Therefore, by activating AMPK, there's potential modulation in the cellular environment where IGFBP4 functions. Through these chemicals, we grasp the vast interconnected nature of cellular pathways and the intricate balance that exists, highlighting how they can shape IGFBP4's role within the cell.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor that affects PI3K/Akt signaling. As Akt can modulate IGF signaling, this inhibitor may indirectly influence IGFBP4 levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor that affects the mTOR pathway. Given mTOR's role in IGF signaling, it can indirectly influence IGFBP4's activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor that impacts the MAPK/ERK pathway. By modulating this pathway, it can influence processes that regulate IGFBP4 expression.

A-769662

844499-71-4sc-203790
sc-203790A
sc-203790B
sc-203790C
sc-203790D
10 mg
50 mg
100 mg
500 mg
1 g
$180.00
$726.00
$1055.00
$3350.00
$5200.00
23
(2)

AMPK activator. By promoting AMPK activity, which can counteract IGF signaling, it may indirectly modulate IGFBP4 levels.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Another PI3K inhibitor. By impacting the PI3K pathway, it might indirectly adjust the levels or activity of IGFBP4.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor. By affecting the p38 MAPK pathway, it can potentially modulate processes that indirectly impact IGFBP4.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor. JNK pathways interact with IGF signaling, and thus, this inhibitor can indirectly affect IGFBP4-associated functions.

Metformin-d6, Hydrochloride

1185166-01-1sc-218701
sc-218701A
sc-218701B
1 mg
5 mg
10 mg
$286.00
$806.00
$1510.00
1
(1)

An AMPK activator. Given its influence on cellular energy balance, it may indirectly affect IGFBP4 in contexts where IGF signaling is active.

ZSTK 474

475110-96-4sc-475495
5 mg
$75.00
(0)

Another PI3K inhibitor. Its influence on the PI3K pathway can have indirect implications on IGFBP4.

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$67.00
$306.00
2
(1)

GSK-3β inhibitor. Given the interplay between GSK-3β and IGF signaling, this inhibitor can have implications on IGFBP4's function.